The United States Agency for International Development (USAID) granted funding to FHI 360 for the implementation of Act to End Neglected Tropical Disease West (Act | West) program from July 19, 2018–July 18, 2023. The program is part of the global effort to eliminate neglected tropical diseases (NTDs). It particularly aims to eliminate lymphatic filariasis (LF), trachoma, and onchocerciasis (OV) (in certain countries) and control schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) in 11 endemic West African countries—including Burkina Faso, Benin, Cameroon, Guinea, Ghana, Côte D’Ivoire, Mali, Niger, Senegal, Sierra Leone, and Togo. It also supports achievement of sustainable service delivery, with growing ownership of national governments in the elimination and/or control of NTDs. This report outlines the key achievements and challenges in the first six months of the second year of program implementation, spanning the period April 1, 2020–September 30, 2020.
This report outlines the key achievements and challenges in the first six months of the second year of implementation of USAID's Act to End NTDs | West Program, spanning the period October 1, 2019–March 31, 2020.
This brochure summarizes the work of USAID's Act to End NTDs | West Program, providing a big picture look at program activities and progress to date as we continue taking action to disrupt the damage of debilitating diseases of poverty. Built on a foundation of broad international cooperation and implemented by a strong consortium of deeply committed partners, led by FHI 360, Act | West works closely with the governments of 11 African countries to eliminate and control five of the world’s most common NTDs over the long term.
The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.
West African neglected tropical diseases (NTD) programs have made great progress toward the elimination/control of NTDs amenable to preventive chemotherapy. However, some districts have failed impact surveys—notably for lymphatic filariasis and trachoma—due to implementation inadequacies, despite reporting good mass treatment coverage. A quality improvement framework has been initiated to strengthen country program interventions and address issues that hinder their ability to achieve the World Health Organization NTD road map elimination/control goals.
The workshop aims to present an innovative model for improving implementation and discuss ideas, strategies, and plans for initiating quality improvement (QI) activities. Experiences from Ghana and Sierra Leone in the design and implementation of the QI model will be shared.
The gender strategy contains an actionable set of recommendations, based on literature and quantitative and qualitative data, intended to contribute to the overall achievement of Act to End NTDs | West program objectives as well as increased gender equality throughout program implementation.